Gamma delta beta-thalassemia due to a de novo mutation deleting the 5' beta-globin gene activation-region hypersensitive sites - PubMed (original) (raw)

Gamma delta beta-thalassemia due to a de novo mutation deleting the 5' beta-globin gene activation-region hypersensitive sites

M C Driscoll et al. Proc Natl Acad Sci U S A. 1989 Oct.

Abstract

gamma delta beta-Thalassemia is a rare disorder of hemoglobin biosynthesis, characterized molecularly by partial or complete deletions of the beta-globin gene complex of 100 kilobases (kb) or greater. Common to all mutants described has been the deletion of the most-5' sequences of the beta-globin complex. We have used the techniques of pulsed-field gel electrophoresis and polymerase chain reaction to study a patient with a clinical gamma delta beta-thalassemia phenotype. This subject developed a de novo deletion on a maternally inherited beta-globin gene chromosome involving approximately 30 kb of sequences 5' to the epsilon gene; the deletion extends from -9.5 kb to -39 kb 5' of epsilon and includes three of the four DNase I hypersensitive sites (at -10.9 kb, -14.7 kb, and -18 kb 5' of epsilon). The remaining sequences of the beta-globin complex, including the DNase I hypersensitive sites at -6.1 kb and all structural genes in cis to the deletion are physically intact, but presumably nonfunctional, as evidenced by the presence of a beta S-globin gene that is not expressed as a sickle hemoglobin. Deletion of DNase I hypersensitive sites on a previously functional beta-globin gene complex confirms the significance of these sites in regulating globin gene expression.

PubMed Disclaimer

Cited by

Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease.
Chauhan W, Zennadi R. Chauhan W, et al. Antioxidants (Basel). 2023 Mar 17;12(3):740. doi: 10.3390/antiox12030740. Antioxidants (Basel). 2023. PMID: 36978988 Free PMC article. Review.
Toward a comprehensive catalog of regulatory elements.
Fan K, Pfister E, Weng Z. Fan K, et al. Hum Genet. 2023 Aug;142(8):1091-1111. doi: 10.1007/s00439-023-02519-3. Epub 2023 Mar 19. Hum Genet. 2023. PMID: 36935423 Review.
Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications.
Kneppers J, Bergman AM, Zwart W. Kneppers J, et al. Adv Exp Med Biol. 2022;1390:255-275. doi: 10.1007/978-3-031-11836-4_15. Adv Exp Med Biol. 2022. PMID: 36107324 Review.
HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription.
Huang P, Peslak SA, Ren R, Khandros E, Qin K, Keller CA, Giardine B, Bell HW, Lan X, Sharma M, Horton JR, Abdulmalik O, Chou ST, Shi J, Crossley M, Hardison RC, Cheng X, Blobel GA. Huang P, et al. Nat Genet. 2022 Sep;54(9):1417-1426. doi: 10.1038/s41588-022-01152-6. Epub 2022 Aug 8. Nat Genet. 2022. PMID: 35941187 Free PMC article.
Case Report: Clinical and Hematological Characteristics of ε_γδβ_ Thalassemia in an Italian Patient.
Fotzi I, Pegoraro F, Chiocca E, Casini T, Mogni M, Veltroni M, Favre C. Fotzi I, et al. Front Pediatr. 2022 Mar 17;10:839775. doi: 10.3389/fped.2022.839775. eCollection 2022. Front Pediatr. 2022. PMID: 35372167 Free PMC article.

References

1. Nature. 1989 Mar 23;338(6213):352-5 - PubMed
1. Proc Natl Acad Sci U S A. 1989 Jan;86(1):37-41 - PubMed
1. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2554-8 - PubMed
1. Genes Dev. 1989 Mar;3(3):314-23 - PubMed
1. N Engl J Med. 1972 Jan 20;286(3):129-34 - PubMed

Gamma delta beta-thalassemia due to a de novo mutation deleting the 5' beta-globin gene activation-region hypersensitive sites - PubMed (original) (raw)